Study to Evaluate the Safety and Anti-tumor Activity of SCC244

NCT03466268 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Gumarontinib Tablets

Sponsor

Haihe Biopharma Co., Ltd.